1.
Arch. endocrinol. metab. (Online)
; 63(6): 646-652, Nov.-Dec. 2019.
Artigo
em Inglês
| LILACS
| ID: biblio-1055016
RESUMO
ABSTRACT Advances in combination medical treatment have offer new perspectives for acromegaly patients with persistent disease activity despite receiving the available medical monotherapies. The outcomes of combination medical treatment may reflect both additive and synergistic effects. This review focuses on combination medical treatment and its current position in acromegaly, based on clinical studies evaluating the efficacy and safety of combined medical treatment(s) and our own experiences with combination therapy. Arch Endocrinol Metab. 2019;63(6):646-52
Assuntos
Humanos , Somatostatina/análogos & derivados , Receptores de Somatostatina/administração & dosagem , Receptores de Somatostatina/antagonistas & inibidores , Agonistas de Dopamina/administração & dosagem , Hormônio do Crescimento Humano/análogos & derivados , Qualidade de Vida , Acromegalia/tratamento farmacológico , Somatostatina/administração & dosagem , Hormônio do Crescimento Humano/administração & dosagem , Quimioterapia Combinada
2.
Arch. endocrinol. metab. (Online)
; 63(4): 318-319, July-Aug. 2019.
Artigo
em Inglês
| LILACS
| ID: biblio-1019357